DK118182A - Fremgangsmaade til fremstilling af humane hybridoma - Google Patents

Fremgangsmaade til fremstilling af humane hybridoma Download PDF

Info

Publication number
DK118182A
DK118182A DK118182A DK118182A DK118182A DK 118182 A DK118182 A DK 118182A DK 118182 A DK118182 A DK 118182A DK 118182 A DK118182 A DK 118182A DK 118182 A DK118182 A DK 118182A
Authority
DK
Denmark
Prior art keywords
hybridoms
manufacturing human
human
manufacturing
human hybridoms
Prior art date
Application number
DK118182A
Other languages
Danish (da)
English (en)
Inventor
Henry S Kaplan
Lennart Olsson
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK118182A publication Critical patent/DK118182A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK118182A 1980-07-18 1982-03-17 Fremgangsmaade til fremstilling af humane hybridoma DK118182A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17025580A 1980-07-18 1980-07-18
PCT/US1981/000957 WO1982001461A1 (en) 1980-07-18 1981-07-15 Human hybridomas,precursors and products

Publications (1)

Publication Number Publication Date
DK118182A true DK118182A (da) 1982-03-19

Family

ID=22619173

Family Applications (1)

Application Number Title Priority Date Filing Date
DK118182A DK118182A (da) 1980-07-18 1982-03-17 Fremgangsmaade til fremstilling af humane hybridoma

Country Status (6)

Country Link
EP (1) EP0044722A1 (ja)
JP (1) JPS57502090A (ja)
CA (1) CA1193562A (ja)
DK (1) DK118182A (ja)
IL (1) IL63354A (ja)
WO (1) WO1982001461A1 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544632A (en) * 1981-06-12 1985-10-01 Yuichi Yamamura Human T cell lines and method of producing same
US4647535A (en) * 1981-08-12 1987-03-03 Research Corporation Human nonsecretory plasmacytoid cell line
WO1983002058A1 (en) * 1981-12-08 1983-06-23 Univ South Carolina Human monoclonal antibodies or lymphokines in separation of cells or diagnosis of mammary cancer
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
JPS58201994A (ja) * 1982-05-21 1983-11-25 Hideaki Hagiwara 抗原特異的ヒト免疫グロブリンの生産方法
CA1247538A (en) * 1982-05-21 1988-12-28 Mark C. Glassy Human-human hybridomas for solid tumors
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
US4689299A (en) * 1982-09-30 1987-08-25 University Of Rochester Human monoclonal antibodies against bacterial toxins
CA1262238A (en) 1982-09-30 1989-10-10 Richard Insel Human monoclonal antibodies against bacterial toxins
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells
US4693966A (en) * 1983-03-11 1987-09-15 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies from lymphocytes of patients with malignant melanoma
JPS59169492A (ja) * 1983-03-15 1984-09-25 Asahi Chem Ind Co Ltd ヒト融合細胞からの生理活性物質の産生方法
CA1218947A (en) * 1983-04-06 1987-03-10 Pearl M.J. Chen Human hybrid cell lines
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4761377A (en) * 1984-10-15 1988-08-02 The Regents Of The University Of California Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
US5001065A (en) * 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
AU734089B2 (en) 1996-10-01 2001-06-07 Geron Corporation Human telomerase catalytic subunit
US6475789B1 (en) 1996-10-01 2002-11-05 University Technology Corporation Human telomerase catalytic subunit: diagnostic and therapeutic methods
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US6261836B1 (en) * 1996-10-01 2001-07-17 Geron Corporation Telomerase
US7622549B2 (en) 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
NZ504292A (en) * 1997-11-10 2003-03-28 Cytimmune Sciences Inc Methods and compositions for enhancing immune response using a targeted delivery system and for the production of in vitro mabs
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US20030055231A1 (en) 1998-10-28 2003-03-20 Jian Ni 12 human secreted proteins
US7413737B2 (en) * 2003-11-14 2008-08-19 Massachusetts Institute Of Technology Anti-hydroxylase antibodies and uses thereof
CA2548179A1 (en) 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
US8859278B2 (en) 2005-08-26 2014-10-14 The Trustees Of Columbia University In The City Of New York Fully human hybridoma fusion partner cell lines
EP2219458B1 (en) 2007-11-08 2015-07-15 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Also Published As

Publication number Publication date
CA1193562A (en) 1985-09-17
EP0044722A1 (en) 1982-01-27
WO1982001461A1 (en) 1982-05-13
IL63354A (en) 1984-12-31
IL63354A0 (en) 1981-10-30
JPS57502090A (ja) 1982-11-25

Similar Documents

Publication Publication Date Title
DK118182A (da) Fremgangsmaade til fremstilling af humane hybridoma
DK155665C (da) Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
DK180481A (da) Fremgangsmaade til fremstilling af metaller
DK417981A (da) Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater
DK88081A (da) Fremgangsmaade til fremstilling af tetrazolderivater
DK150623C (da) Fremgangsmaade til fremstilling af fiskemel
DK157193C (da) Analogifremgangsmaade til fremstilling af carbostyrilforbindelser
DK319281A (da) Femgangsmaade til fremstilling af benzisoselenazoloner
DK145033C (da) Fremgangsmaade til fremstilling af bloed iscreme
DK582883D0 (da) Fremgangsmaade til fremstilling af modelis
DK479981A (da) Fremgangsmaade til fremstilling af 3-aryl-3-hydroxyphthalimidiner
DK460182A (da) Fremgangsmaade til fremstilling af staphylokinase
DK68981A (da) Fremgangsmaade til fremstilling af oel
DK431081A (da) Fremgangsmaade til behandling af trae
DK231481A (da) Fremgangsmaade til fremstilling af diacetonektetogulonsyre
DK331381A (da) Fremgangsmaade til fremstilling af 1-klor-1-pmetoxybenzoylformaldoxim-n-metylkarbamat
DK548081A (da) Fremgangsmaade til fremstilling af buspiron
DK342981A (da) Fremgangsmaade til selektiv fremstilling af m-chloraniliner
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK105082A (da) Fremgangsmaade til fremstilling af substituerede trifluormethylphenyl-tetrahydropyridiner
DK574281A (da) Fremgangsmaade til selektiv fremstilling af m-chlorphenolder
DK574181A (da) Fremgangsmaade til selektiv fremstilling af m-chlorphenoler
DK238081A (da) Fremgangsmaade til fremstilling af tetramisolanaloge
DK385381A (da) Fremgangsmaade til fremstilling af pyraziner
DK118382A (da) Fremgangsmaade til fremstilling af anthelmintika

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment